Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Otorhinolaryngology

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 145 articles:
HTML format



Single Articles


    July 2022
  1. PRICE JM, West CM, Dixon LM, Iyizoba-Ebozue Z, et al
    Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
    Radiother Oncol. 2022;172:111-117.
    PubMed     Abstract available


    June 2022
  2. QIAN D, Chen X, Shang X, Wang Y, et al
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II rando
    Radiother Oncol. 2022 Jun 25. pii: S0167-8140(22)04176.
    PubMed     Abstract available


  3. KROESE TE, Christ SM, van Rossum PSN, Burger MDL, et al
    Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study.
    Radiother Oncol. 2022 Jun 23. pii: S0167-8140(22)04173.
    PubMed     Abstract available


  4. GONG J, Zhang W, Huang W, Liao Y, et al
    CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study.
    Radiother Oncol. 2022 Jun 21. pii: S0167-8140(22)04171.
    PubMed     Abstract available


  5. HANSEN CR, Price G, Field M, Sarup N, et al
    Open-source distributed learning validation for a larynx cancer survival model following radiotherapy.
    Radiother Oncol. 2022 Jun 20. pii: S0167-8140(22)04170.
    PubMed     Abstract available


  6. FU G, Xie Y, Pan J, Qiu Y, et al
    Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Jun 16. pii: S0167-8140(22)04164.
    PubMed     Abstract available


  7. SCHOONBEEK RC, Festen S, van der Laan BFAM, Plaat BEC, et al
    The effect of delayed treatment initiation on adverse events and recurrence in older head and neck cancer patients.
    Radiother Oncol. 2022 Jun 6. pii: S0167-8140(22)04146.
    PubMed     Abstract available


  8. MASSACCESI M, Dinapoli N, Fuga V, Rupe C, et al
    A predictive nomogram for trismus after radiotherapy for head and neck cancer.
    Radiother Oncol. 2022 Jun 2. pii: S0167-8140(22)04137.
    PubMed     Abstract available


    May 2022
  9. LIU Z, Luo Y, Guo R, Yang B, et al
    Head and Neck Radiotherapy Causes Significant Disruptions of Cochlear Ribbon Synapses and Consequent Sensorineural Hearing Loss.
    Radiother Oncol. 2022 May 28. pii: S0167-8140(22)02279.
    PubMed     Abstract available


  10. ZHAO DW, Fan WJ, Fang XM, Luo YR, et al
    Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Radiother Oncol. 2022 May 15. pii: S0167-8140(22)00251.
    PubMed     Abstract available


  11. YI-LIANG SHEN E, Hung TM, Tsan DL, Cheng NM, et al
    Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein-barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 May 11. pii: S0167-8140(22)00240.
    PubMed     Abstract available


    April 2022
  12. ZHAO Y, Liao X, Wang Y, Lan W, et al
    Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
    Radiother Oncol. 2022 Apr 29. pii: S0167-8140(22)00232.
    PubMed     Abstract available


  13. DOHOPOLSKI M, Wang K, Morgan H, Sher D, et al
    Predicting the need for aggressive nutritional supplementation in head and neck cancer patients receiving radiation therapy.
    Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00224.
    PubMed     Abstract available


  14. SHEN H, Yin J, Niu R, Lian Y, et al
    Development and validation of a radiomic nomogram to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carc
    Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00222.
    PubMed     Abstract available


  15. LEE BM, Lee CG
    Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer.
    Radiother Oncol. 2022 Apr 18. pii: S0167-8140(22)00191.
    PubMed     Abstract available


  16. WELZ S, Paulsen F, Pfannenberg C, Reimold M, et al
    Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [(18)F]FMISO PET/CT.
    Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00170.
    PubMed     Abstract available


  17. JENSEN KH, Vogelius IR, Bernsdorf M, Gothelf A, et al
    Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma.
    Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00169.
    PubMed     Abstract available


  18. LUDWIG R, Hoffmann JM, Pouymayou B, Dappen MB, et al
    Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface.
    Radiother Oncol. 2022;169:1-7.
    PubMed     Abstract available


    March 2022
  19. YUE M, Xue X, Wang Z, Lambo RL, et al
    Dose prediction via distance-guided deep learning: initial development for nasopharyngeal carcinoma radiotherapy.
    Radiother Oncol. 2022 Mar 26. pii: S0167-8140(22)00150.
    PubMed     Abstract available


  20. BORDERIAS-VILLARROEL E, Taasti V, Van Elmpt W, Teruel-Rivas S, et al
    Evaluation of the clinical value of automatic online dose restoration for adaptive proton therapy of head and neck cancer.
    Radiother Oncol. 2022 Mar 25. pii: S0167-8140(22)00149.
    PubMed     Abstract available


  21. KARAVOLIA E, van Rijn-Dekker MI, Van den Bosch L, van den Hoek JGM, et al
    Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
    Radiother Oncol. 2022 Mar 15. pii: S0167-8140(22)00145.
    PubMed     Abstract available


  22. ZHOU X, Wang W, Zhou C, Zhu J, et al
    Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00132.
    PubMed     Abstract available


  23. HUANG CC, Lai YR, Chiu WC, Fang FM, et al
    Concurrent chemoradiation therapy is associated with an accelerated risk of cardiovascular autonomic dysfunction in patients with nasopharyngeal carcinoma: A 9-year prospective follow-up study.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00129.
    PubMed     Abstract available


  24. CHOW R, Simone CB 2nd
    Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality.
    Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00112.
    PubMed    


  25. DAI D, Tian Q, Shui Y, Li J, et al
    Response to "Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality".
    Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00109.
    PubMed    


  26. NACHANKAR A, Musha A, Kubo N, Kawamura H, et al
    Dosimetric analysis of intraocular hemorrhage in nonsquamous head and neck cancers treated with carbon-ion radiotherapy.
    Radiother Oncol. 2022 Mar 4. pii: S0167-8140(22)00118.
    PubMed     Abstract available


  27. GORPHE P, Classe M, Ammari S, Garcia G, et al
    Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma.
    Radiother Oncol. 2022;168:40-45.
    PubMed     Abstract available


    February 2022
  28. LASKAR SG, Sinha S, Pai DP, Nair D, et al
    Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes.
    Radiother Oncol. 2022 Feb 24. pii: S0167-8140(22)00106.
    PubMed     Abstract available


  29. BONOMO P, Desideri I, Mangoni M, Saieva C, et al
    Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: a phase 1/2 trial.
    Radiother Oncol. 2022 Feb 11. pii: S0167-8140(22)00091.
    PubMed     Abstract available


  30. SCANDURRA D, Meijer TWH, Free J, van den Hoek JGM, et al
    Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Feb 5. pii: S0167-8140(22)00080.
    PubMed     Abstract available


  31. PAN D, Rong X, Zhu Y, Ng WT, et al
    A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis.
    Radiother Oncol. 2022 Feb 1. pii: S0167-8140(22)00060.
    PubMed     Abstract available


    January 2022
  32. SUN XS, Zhu MY, Wen DX, Luo DH, et al
    Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in local recurrence nasopharyngeal carcinoma patients.
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00028.
    PubMed     Abstract available


  33. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Head and neck cancer diagnoses and faster treatment initiation during COVID-19: correspondence.
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00026.
    PubMed    


  34. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
    Response to "Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence".
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00033.
    PubMed    


  35. CHATTERJEE S, Maulik S, Prasath S, Arun B, et al
    Xerostomia quality of life and resource requirements following parotid sparing adaptive radiotherapy in head and neck cancers: Results of a prospective cohort study (Study ID CTRI/2017/11/010683).
    Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00024.
    PubMed     Abstract available


  36. ZECH HB, Berger J, Mansour WY, Nordquist L, et al
    Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
    Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00022.
    PubMed     Abstract available


  37. AL-MAMGANI A, Kessels R, Janssen T, Navran A, et al
    The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6mm in head and neck squamous cell carcinoma: significant acute and late toxicity reduction.
    Radiother Oncol. 2022 Jan 20. pii: S0167-8140(22)00017.
    PubMed     Abstract available


  38. HE J, Qian L, Gao J
    Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00005.
    PubMed    


  39. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)"by He et al.
    Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00006.
    PubMed    


  40. DAI D, Tian Q, Shui Y, Li J, et al
    The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis.
    Radiother Oncol. 2022 Jan 8. pii: S0167-8140(22)00007.
    PubMed     Abstract available


  41. HUANG W, Zhang Q, Wu G, Chen P, et al
    Corrigendum to "DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients" [Radiother Oncol (2021) 164:146-154].
    Radiother Oncol. 2022 Jan 7. pii: S0167-8140(21)09059.
    PubMed    


  42. LIU T, Shen BW, Liu LT, Yang ZC, et al
    Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model.
    Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09094.
    PubMed     Abstract available


  43. FORNER LE, Dieleman FJ, Shaw RJ, Kanatas A, et al
    Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1.
    Radiother Oncol. 2022;166:137-144.
    PubMed     Abstract available


    December 2021
  44. GUO Q, Xiao N, Xu H, Zong J, et al
    Rationality of the international guideline's recommendation regarding selective coverage of level Ib in clinical target volume with nasopharyngeal carcinoma: Results from a real-world series.
    Radiother Oncol. 2021 Dec 29. pii: S0167-8140(21)09081.
    PubMed     Abstract available


  45. TANG SQ, Chen L, Li WF, Chan ATC, et al
    Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9,468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial.
    Radiother Oncol. 2021 Dec 28. pii: S0167-8140(21)09077.
    PubMed     Abstract available


  46. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
    Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis.
    Radiother Oncol. 2021 Dec 13. pii: S0167-8140(21)09049.
    PubMed     Abstract available


  47. MUSHA A, Hirai C, Kitada Y, Tsunoda A, et al
    Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
    Radiother Oncol. 2021 Dec 10. pii: S0167-8140(21)09054.
    PubMed     Abstract available


  48. BEUKEMA JC, de Groot C, Plukker JTM, Vliegenthart R, et al
    Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: a prospective cross-sectional pilot study.
    Radiother Oncol. 2021 Dec 2. pii: S0167-8140(21)09025.
    PubMed     Abstract available


    November 2021
  49. KUTZ LM, Abel J, Schweizer D, Tribius S, et al
    Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09004.
    PubMed     Abstract available


  50. JIN YN, Yang QQ, Li ZQ, Ou XQ, et al
    Development of a Web-based Prognostic Model to Quantify the Survival Benefit of Cumulative Cisplatin Dose during Concurrent Chemoradiotherapy in Childhood Nasopharyngeal Carcinoma.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09008.
    PubMed     Abstract available


  51. NISHIBUCHI I, Murakami Y, Kubo K, Imano N, et al
    Temporal Changes and Risk Factors for Esophageal Stenosis after Salvage Radiotherapy in Superficial Esophageal Cancer following Non-Curative Endoscopic Submucosal Dissection.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09007.
    PubMed     Abstract available


  52. PATEL V, Kwok J, Burke M, Urbano TG, et al
    Should the HPV positive oropharyngeal cancer patient be considered for a two-stage dental assessment for their radiation treatment?
    Radiother Oncol. 2021;164:232-235.
    PubMed     Abstract available


  53. GAWRYSZUK A, Bijl HP, van der Schaaf A, Perdok N, et al
    Relationship between videofluoroscopic and subjective (physician- and patient- rated) assessment of late swallowing dysfunction after (chemo) radiation: Results of a prospective observational study.
    Radiother Oncol. 2021;164:253-260.
    PubMed     Abstract available


    October 2021
  54. BROOKER RC, Antczak P, Liloglou T, Risk JM, et al
    Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy.
    Radiother Oncol. 2021;165:87-93.
    PubMed     Abstract available


  55. CHIN O, Yu E, O'Sullivan B, Su J, et al
    Prognostic Importance of Radiologic Extranodal Extension in Nasopharyngeal Carcinoma Treated in a Canadian Cohort.
    Radiother Oncol. 2021 Oct 27. pii: S0167-8140(21)08785.
    PubMed     Abstract available


  56. ZHANG ZM, Zhao R, Bao Y, Zhou LX, et al
    A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08758.
    PubMed     Abstract available


  57. SHI Z, Zhu X, Ke S, Qiu H, et al
    Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: a propensity score matching and landmark analyses.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08754.
    PubMed     Abstract available


  58. YAN A, Hanna A, Wilson TG, Deraniyagala R, et al
    Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)08748.
    PubMed     Abstract available


  59. KANEHIRA T, van Kranen S, Jansen T, Hamming-Vrieze O, et al
    Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)06738.
    PubMed     Abstract available


    September 2021
  60. HUANG W, Zhang Q, Wu G, Pian Chen P, et al
    DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
    Radiother Oncol. 2021 Sep 27. pii: S0167-8140(21)06739.
    PubMed     Abstract available


  61. WAGENAAR D, Schuit E, van der Schaaf A, Langendijk JA, et al
    Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06723.
    PubMed     Abstract available


  62. WANG X, Hobbs B, Gandhi SJ, Muijs CT, et al
    Current Status and Application of Proton Therapy for Esophageal Cancer.
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06724.
    PubMed     Abstract available


  63. CHOW JCH, Lee A, Bao KKH, Cheung KM, et al
    Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.
    Radiother Oncol. 2021 Sep 7. pii: S0167-8140(21)06716.
    PubMed     Abstract available


    August 2021
  64. KROESE TE, Jairam J, Ruurda JP, Lin SH, et al
    Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: incidence and external validation of a prediction model.
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06703.
    PubMed     Abstract available


  65. LIU T, Liu LT, Lin JY, Shen BW, et al
    Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06704.
    PubMed     Abstract available


  66. WENTZEL A, Luciani T, van Dijk LV, Taku N, et al
    Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas.
    Radiother Oncol. 2021;161:152-158.
    PubMed     Abstract available


  67. N B P, Ravi KS, Durgapal P
    Discovery of new salivary gland - A substantial histological analysis.
    Radiother Oncol. 2021;161:92-94.
    PubMed     Abstract available


  68. GREGOIRE V, Bauwens L
    Reply to sanguineti regarding the manuscript untitled "Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma".
    Radiother Oncol. 2021;161:253.
    PubMed    


  69. SANGUINETI G
    Re: Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol, 2021. 157: p. 122-129.
    Radiother Oncol. 2021;161:251-252.
    PubMed    


    July 2021
  70. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Corrigendum to "Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: Proposed modification in the current UICC/AJCC staging system" [Radiother Oncol 160 (2021) 221-227].
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06644.
    PubMed    


  71. YANG G, Feng D, Li F, Luo B, et al
    A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06667.
    PubMed     Abstract available


  72. PARSAI S, Lei J Qiu R, Qi P, Sedor G, et al
    In Vivo Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology Implementation.
    Radiother Oncol. 2021 Jul 29. pii: S0167-8140(21)06666.
    PubMed     Abstract available


  73. AL-MAMGANI A, Kessels R, Navran A, Hamming-Vrieze O, et al
    Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes.
    Radiother Oncol. 2021 Jul 23. pii: S0167-8140(21)06659.
    PubMed     Abstract available


  74. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06639.
    PubMed    


  75. MUNARETTO TIMM BAIOCCHI J, Fischer-Sgrott F, Baiocchi Neto G
    Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06642.
    PubMed    


  76. JO YY, Yu J, Song KJ, Jang JY, et al
    Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: a retrospective study.
    Radiother Oncol. 2021 Jul 12. pii: S0167-8140(21)06643.
    PubMed     Abstract available


  77. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06626.
    PubMed     Abstract available


  78. VAN DER LAAN HP, van der Schaaf A, Van den Bosch L, Korevaar EW, et al
    Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06623.
    PubMed     Abstract available


  79. CAO J, Zhang X, Jiang B, Chen J, et al
    Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
    Radiother Oncol. 2021;160:32-39.
    PubMed     Abstract available


    June 2021
  80. SUN XS, Xie SY, Luo DH, Liu LT, et al
    Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016.
    Radiother Oncol. 2021 Jun 25. pii: S0167-8140(21)06612.
    PubMed     Abstract available


  81. DONNELLY O, Goranova R, Nugent M
    Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
    Radiother Oncol. 2021 Jun 15. pii: S0167-8140(21)06579.
    PubMed    


  82. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06581.
    PubMed    


  83. JIN YN, Yao JJ, You YF, Cao HJ, et al
    Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
    Radiother Oncol. 2021 Jun 8. pii: S0167-8140(21)06575.
    PubMed     Abstract available


  84. DE BREE R, Swartz JE, Bril S, Chargi N, et al
    Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients.
    Radiother Oncol. 2021 Jun 6. pii: S0167-8140(21)06573.
    PubMed    


    May 2021
  85. JIANG C, Gong B, Gao H, Zhang T, et al
    Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).
    Radiother Oncol. 2021 May 24. pii: S0167-8140(21)06258.
    PubMed     Abstract available


  86. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Radiother Oncol. 2021 May 13. pii: S0167-8140(21)06241.
    PubMed     Abstract available


  87. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Extent of Paranasal Sinus Involvement and its Prognostic Value in Nasopharyngeal Carcinoma: Proposed Modification in the Current UICC/AJCC staging system.
    Radiother Oncol. 2021 May 10. pii: S0167-8140(21)06224.
    PubMed     Abstract available


  88. SUN Z, Hu S, Xue Q, Jin L, et al
    Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?
    Radiother Oncol. 2021 May 2. pii: S0167-8140(21)06214.
    PubMed     Abstract available


    April 2021
  89. TAMBAS M, der Laan HPV, Rutgers W, van den Hoek JGM, et al
    Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06194.
    PubMed     Abstract available


  90. VAN DER LAAN HP, Van den Bosch L, Schuit E, Steenbakkers RJHM, et al
    aImpact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06193.
    PubMed     Abstract available


  91. ELICIN O, Koller Brolese E, Bojaxhiu B, Sermaxhaj B, et al
    The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer.
    Radiother Oncol. 2021 Apr 10. pii: S0167-8140(21)06185.
    PubMed     Abstract available


  92. ESTEBAN B, Pierre P, Camille S, Pascal P, et al
    Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: a multicentric study using propensity score.
    Radiother Oncol. 2021 Apr 9. pii: S0167-8140(21)06183.
    PubMed     Abstract available


  93. LU ZJ, Liu LT, Sun XS, Guo SS, et al
    Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06175.
    PubMed     Abstract available


  94. YAN JJ, Guo SS, Lin DF, Liu LT, et al
    Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06180.
    PubMed     Abstract available


  95. QIU Y, Guo Z, Lin X, Li J, et al
    Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06179.
    PubMed     Abstract available


  96. ZHANG Y, Feng W, Gao LT, Cai XW, et al
    Long-term follow-up of a phase I/II trial of radiation dose escalation by simultaneous integrated boost for locally advanced esophageal squamous cell carcinoma.
    Radiother Oncol. 2021 Apr 1. pii: S0167-8140(21)06171.
    PubMed     Abstract available


  97. WONG ET, Huang SH, O'Sullivan B, Persaud V, et al
    Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
    Radiother Oncol. 2021;157:255-262.
    PubMed     Abstract available


  98. JENSEN GL, Axelrud G, Fink D, Hammonds K, et al
    Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT.
    Radiother Oncol. 2021;157:234-240.
    PubMed     Abstract available


  99. BAUWENS L, Baltres A, Fiani DJ, Zrounba P, et al
    Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2021;157:122-129.
    PubMed     Abstract available


  100. MEN K, Chen X, Yang B, Zhu J, et al
    Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning.
    Radiother Oncol. 2021;157:1-7.
    PubMed     Abstract available


    March 2021
  101. LI G, Jiang Y, Li G, Qiao Q, et al
    Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Mar 25. pii: S0167-8140(21)06143.
    PubMed     Abstract available


  102. LOSER A, Abel J, Magdalena Kutz L, Krause L, et al
    Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: results from the prospective randomized headnut-trial.
    Radiother Oncol. 2021 Mar 22. pii: S0167-8140(21)06145.
    PubMed     Abstract available


  103. RUHLE A, Grosu AL, Wiedenmann N, Stoian R, et al
    Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
    Radiother Oncol. 2021 Mar 19. pii: S0167-8140(21)06140.
    PubMed     Abstract available


  104. GROSSBERG AJ, Rock CD, Edwards J, Mohamed ASR, et al
    Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2021 Mar 15. pii: S0167-8140(21)06131.
    PubMed     Abstract available


  105. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
    Radiother Oncol. 2021 Mar 9. pii: S0167-8140(21)06117.
    PubMed     Abstract available


  106. CHEN B, Deng M, Yang C, Dragomir MP, et al
    High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06094.
    PubMed     Abstract available


  107. BROLESE EK, Cihoric N, Bojaxhiu B, Sermaxhaj B, et al
    The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06113.
    PubMed     Abstract available


  108. HOSNI A, Huang SH, Xu W, Su J, et al
    Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.
    Radiother Oncol. 2021;156:95-101.
    PubMed     Abstract available


    February 2021
  109. HUANG TW, Shao CH, Chiang CC
    Response to the letter to the editor "Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials regards to Chiu et al."
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06086.
    PubMed    


  110. CHIU YH, Wang TG
    Letter to the editor regarding Shao et al., Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06088.
    PubMed    


  111. FAN WJ, Teng F, Liu G, Zhao DW, et al
    Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06050.
    PubMed     Abstract available


  112. NIE D, Wang X, Sun M, Feng Z, et al
    The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06047.
    PubMed     Abstract available


  113. YANG ES, Deutsch E, Mehmet A, Fayette J, et al
    A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Feb 9. pii: S0167-8140(21)06040.
    PubMed     Abstract available


  114. VAN AKEN ESM, Paul van der Laan H, Bijl HP, Van den Bosch L, et al
    Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06023.
    PubMed     Abstract available


  115. VAN DEN BOSCH L, van der Schaaf A, Paul van der Laan H, Hoebers FJP, et al
    Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06021.
    PubMed     Abstract available


  116. MICHAELIDOU A, Adjogatse D, Suh Y, Pike L, et al
    18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO).
    Radiother Oncol. 2021;155:261-268.
    PubMed     Abstract available


  117. ROSEN BS, Wilkie JR, Sun Y, Ibrahim M, et al
    CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Radiother Oncol. 2021;155:174-181.
    PubMed     Abstract available


    January 2021
  118. MAO Y, Wang S, Lydiatt W, Shah JP, et al
    Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
    Radiother Oncol. 2021 Jan 28. pii: S0167-8140(21)00015.
    PubMed     Abstract available


  119. LACAS B, Carmel A, Landais C, Wong SJ, et al
    Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00013.
    PubMed     Abstract available


  120. WEN DW, Lin L, Mao YP, Chen CY, et al
    Comparison of Normal Tissue Complication Probability (NTCP) Models Using Machine Learning for Predicting Temporal Lobe Injury after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: a Large Registry-Based Retrospective Study from China.
    Radiother Oncol. 2021 Jan 20. pii: S0167-8140(21)00008.
    PubMed     Abstract available


  121. HUANG TT, Li SH, Chen YH, Lu HI, et al
    Definitive chemoradiotherapy for clinical T4b esophageal cancer - treatment outcomes, failure patterns, and prognostic factors.
    Radiother Oncol. 2021 Jan 19. pii: S0167-8140(21)00007.
    PubMed     Abstract available


  122. GUO Q, Zheng Y, Lin J, Xu Y, et al
    Modified Reduced-volume Intensity-modulated radiation therapy in Non-metastatic Nasopharyngeal Carcinoma: A Prospective Observation Series.
    Radiother Oncol. 2021 Jan 5. pii: S0167-8140(20)31262.
    PubMed     Abstract available


  123. QIU X, Xu T, Li M, Fei Z, et al
    Response to Chai' letter: What caused the difference in prognosis among different physicians?
    Radiother Oncol. 2021;154:e20-e21.
    PubMed    


    December 2020

  124. Salivary glands at the pharyngeal ostium of the Eustachian tube are already described in histological literature.
    Radiother Oncol. 2020 Dec 30. pii: S0167-8140(20)31248.
    PubMed    


  125. FAN KH, Yeh CH, Hung SP, Kang CJ, et al
    Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
    Radiother Oncol. 2020 Dec 29. pii: S0167-8140(20)31255.
    PubMed     Abstract available


  126. XIANG M, Gensheimer MF, Pollom EL, Holsinger FC, et al
    Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
    Radiother Oncol. 2020 Dec 28. pii: S0167-8140(20)31251.
    PubMed     Abstract available


  127. LIANG SB, Chen LS, Chen HY, Yang XL, et al
    Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: a retrospective study.
    Radiother Oncol. 2020 Dec 10. pii: S0167-8140(20)31231.
    PubMed     Abstract available


    November 2020
  128. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31193.
    PubMed     Abstract available


  129. LIANG SB, Chen LS, Yang XL, Chen DM, et al
    Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.
    Radiother Oncol. 2020 Nov 17. pii: S0167-8140(20)31165.
    PubMed     Abstract available


  130. HIROSE K, Konno A, Hiratsuka J, Yoshimoto S, et al
    Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.
    Radiother Oncol. 2020 Nov 10. pii: S0167-8140(20)30890.
    PubMed     Abstract available


  131. YANG HC, Wu CC, Lee CC, Huang HE, et al
    Prediction of Pseudoprogression and Long-term Outcome of Vestibular Schwannoma after Gamma Knife Radiosurgery based on Preradiosurgical MR Radiomics.
    Radiother Oncol. 2020 Nov 5. pii: S0167-8140(20)30888.
    PubMed     Abstract available


    October 2020
  132. CHEN NB, Li QW, Li S, Guo SP, et al
    Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021).
    Radiother Oncol. 2020 Oct 31. pii: S0167-8140(20)30882.
    PubMed     Abstract available


  133. ZSCHAECK S, Zophel K, Seidlitz A, Zips D, et al
    Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
    Radiother Oncol. 2020;155:204-211.
    PubMed     Abstract available


  134. VAN ROSSUM PSN, Jeene PM, Rozema T, Braam PM, et al
    Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30845.
    PubMed     Abstract available


  135. LUO WJ, Zou WQ, Liang SB, Chen L, et al
    Combining tumor response and personalized risk assessment: potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30841.
    PubMed     Abstract available


  136. HAMILTON SN, Urban R, Liu A, Chau N, et al
    Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer.
    Radiother Oncol. 2020;151:110-117.
    PubMed     Abstract available


  137. LAI TY, Yeh CM, Hu YW, Liu CJ, et al
    Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy.
    Radiother Oncol. 2020;151:190-199.
    PubMed     Abstract available


  138. SHARMA MB, Jensen K, Urbak SF, Funding M, et al
    A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer.
    Radiother Oncol. 2020;151:58-65.
    PubMed     Abstract available


    September 2020
  139. LI J, Wen Y, Xiang Z, Du H, et al
    Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.
    Radiother Oncol. 2020 Sep 24. pii: S0167-8140(20)30817.
    PubMed     Abstract available


    July 2020
  140. WENTZEL A, Hanula P, van Dijk LV, Elgohari B, et al
    Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.
    Radiother Oncol. 2020;148:245-251.
    PubMed     Abstract available


  141. GRANT SR, Hutcheson KA, Ye R, Garden AS, et al
    Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Radiother Oncol. 2020;148:133-139.
    PubMed     Abstract available


    June 2020
  142. MANZAR GS, Lester SC, Routman DM, Harmsen WS, et al
    Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
    Radiother Oncol. 2020;147:64-74.
    PubMed     Abstract available


    April 2020
  143. DE FELICE F, Bird T, Michaelidou A, Thavaraj S, et al
    Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    Radiother Oncol. 2020;145:146-153.
    PubMed     Abstract available


  144. NG SP, Bahig H, Jethanandani A, Pollard C, et al
    Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
    Radiother Oncol. 2020;145:95-100.
    PubMed     Abstract available


    March 2020
  145. HUANG SH, O'Sullivan B, Su J, Bartlett E, et al
    Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
    Radiother Oncol. 2020;144:13-22.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: